The predicted risk of adverse pregnancy outcomes as a result of treatmentassociated obesity in a hypothetical population receiving tenofovir alafenamideemtricitabinedolutegravir tenofovir disoproxil fumarateemtricitabinedolutegravir or tenofovir diso

Simple item page
dc.citation.doi10.1097/QAD.0000000000003020
dc.citation.epage125
dc.citation.spage117
dc.contributor.authorSumbul Asif
dc.contributor.authorEvangelia Baxevanidi
dc.contributor.authorAndrew Hill
dc.contributor.authorWillem Venter
dc.contributor.authorLee Fairlie
dc.contributor.authorMasebole Masenya
dc.contributor.authorCelicia Serenata
dc.contributor.authorSimiso Sokhela
dc.contributor.authorNomathemba Chandiwana
dc.date.accessioned2023-02-28T09:35:56Z
dc.date.available2023-02-28T09:35:56Z
dc.departmentInfectious Diseases
dc.departmentInternal Medicine
dc.identifier.citationWOS
dc.identifier.issn0269-9370
dc.identifier.urihttps://hdl.handle.net/10539/34702
dc.journal.titleAIDS
dc.journal.volume35
dc.titleThe predicted risk of adverse pregnancy outcomes as a result of treatmentassociated obesity in a hypothetical population receiving tenofovir alafenamideemtricitabinedolutegravir tenofovir disoproxil fumarateemtricitabinedolutegravir or tenofovir diso
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal.pdf
Size:
390.27 KB
Format:
Adobe Portable Document Format
Description:
Journal
Download
Collections
Research Outputs (Clinical Medicine)
Academic Wits Research Outputs (All submissions)